Personalized 3D-printed external breast prosthesis after mastectomy
Official title: Patient Reported Outcomes Post-Mastectomy and In-house 3D-printed Individualized External Breast Prostheses
Run by Mayo Clinic · NCT07047872 · Data updated 2026-11-12
This trial will try a custom 3D-printed external breast prosthesis to see if it improves patient-reported outcomes for people who had a mastectomy and did not have reconstruction.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | November 5, 2024 |
| Main results expected | November 5, 2027 |
| Study ends | November 5, 2027 |
| Registry record updated | August 17, 2026 |
| Trial ID | NCT07047872 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who have had unilateral or bilateral mastectomy without implant or autologous reconstruction, can provide informed consent, complete surface scanning and standardized photography, and complete follow-up surveys are ideal candidates.
✕Probably not a fit
Patients with implant or autologous reconstruction, active chest wounds or infections, inability to communicate in the study language, or inability to attend required scans and follow-up visits are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center interventional project uses 3D surface scanning and computer-aided design to create patient-specific external breast prostheses that are manufactured with 3D printing. Adults who have had unilateral or bilateral mastectomy without implant or autologous reconstruction undergo surface scanning (with temporary fiducial skin markers), standardized photography, and receive a customized prosthesis. Patient-reported outcome questionnaires are collected at baseline and at 1, 3, 6, and 12 months to measure comfort, fit, and quality of life. The goal is to determine whether a better-fitting, personalized external prosthesis leads to improved self-reported outcomes over time.
Why it matters
Potential benefit: If successful, patients may experience better comfort, fit, body image, and overall quality of life from a customized external breast prosthesis.
How similar studies have gone: Small feasibility reports and pilot projects of custom or 3D-printed external prostheses have reported improved fit and patient satisfaction, but large controlled trials are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult individuals aged 18 years or older * History of unilateral or bilateral mastectomy for any indication * No implant or autologous reconstruction * Allowed: Goldilocks closure, flat closure, simple skin closure * Willingness to participate in the study by completing PRO assessments or receiving personalized 3D-printed breast prostheses * Ability to provide informed consent * Ability to complete study procedures, including surface scanning (with temporary fiducial skin markers), standardized photography, and surveys at 1, 3, 6, and 12 months Exclusion Criteria: * Individuals with contraindications for participation, such as severe medical conditions that may interfere with study procedures * Lack of willingness or capacity to provide informed consent for study participation * Inability to communicate effectively in the study language (e.g., English) * Patients with open wounds, active infection, or dermatologic conditions at the chest/breast site that would interfere with scanning, fiducial marker placement, or prosthesis use * Patients unwilling or unable to undergo surface scanning, standardized photography, or complete survey follow-up
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Aparna Vijayasekaran, MBBS — Mayo Clinic
- Study coordinator: Aparna Vijayasekaran
- Email: vijayasekaran.aparna@mayo.edu
- Phone: 507-538-1701
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile health navigation to improve breast cancer screening in Kenyan women
This study tests m-Health patient navigation tools to help women in Kenya access breast cancer screening and early detection services.
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Environmental exposure checks in high-risk and early-onset breast cancer care
This study tests how patients and providers feel about using environmental exposure risk data in breast cancer care for women at average/high risk or with early-onset breast cancer.
-
CSF sample collection from people with metastatic breast cancer to see brain metastasis risk
This study tests whether spinal fluid and other samples can help predict brain metastases in adults with metastatic HER2-positive or triple-negative breast cancer who have not yet shown brain involvement.
-
Body composition and outcomes after breast reconstruction
This study will see if detailed body composition measurements can help predict complications after mastectomy with immediate breast reconstruction in adult women.
-
Support tool for women with HR+ breast cancer on long-term endocrine therapy
This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.